CY1115439T1 - Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου - Google Patents

Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου

Info

Publication number
CY1115439T1
CY1115439T1 CY20141100599T CY141100599T CY1115439T1 CY 1115439 T1 CY1115439 T1 CY 1115439T1 CY 20141100599 T CY20141100599 T CY 20141100599T CY 141100599 T CY141100599 T CY 141100599T CY 1115439 T1 CY1115439 T1 CY 1115439T1
Authority
CY
Cyprus
Prior art keywords
disorders
analysis
methods
cell property
nuclear acids
Prior art date
Application number
CY20141100599T
Other languages
Greek (el)
English (en)
Inventor
Volker Liebenberg
Jürgen Distler
Jörn Lewin
Fabian Model
Reimo Tetzner
Rene Cortese
Original Assignee
Epigenomics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenomics Ag filed Critical Epigenomics Ag
Publication of CY1115439T1 publication Critical patent/CY1115439T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CY20141100599T 2007-01-19 2014-08-04 Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου CY1115439T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07100829 2007-01-19
EP07110019 2007-06-11
EP07113449 2007-07-30
EP10156846.7A EP2258871B1 (en) 2007-01-19 2008-01-18 Methods and nucleic acids for analyses of cell proliferative disorders

Publications (1)

Publication Number Publication Date
CY1115439T1 true CY1115439T1 (el) 2017-01-04

Family

ID=39430717

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100599T CY1115439T1 (el) 2007-01-19 2014-08-04 Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου

Country Status (15)

Country Link
EP (2) EP2258871B1 (enExample)
JP (2) JP5342456B2 (enExample)
AT (1) ATE549418T1 (enExample)
AU (1) AU2008207110B2 (enExample)
CA (2) CA2675895C (enExample)
CY (1) CY1115439T1 (enExample)
DK (1) DK2258871T3 (enExample)
EA (1) EA018010B1 (enExample)
ES (2) ES2384071T3 (enExample)
HR (1) HRP20140692T1 (enExample)
IL (2) IL199894A (enExample)
PL (1) PL2258871T3 (enExample)
PT (1) PT2258871E (enExample)
SI (1) SI2258871T1 (enExample)
WO (1) WO2008087040A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9090941B2 (en) 2006-12-19 2015-07-28 Cornell Research Foundation, Inc. Use of lecithin:retinol acyl transferase gene promoter methylation in evaluating the cancer state of subject
ES2384071T3 (es) * 2007-01-19 2012-06-29 Epigenomics Ag Métodos y ácidos nucleicos para análisis de trastornos proliferativos celulares
US8399193B2 (en) * 2007-08-30 2013-03-19 City Of Hope DNA methylation biomarkers for lung cancer
JP5694776B2 (ja) * 2007-12-11 2015-04-01 エピゲノミクス アーゲー 細胞増殖性障害の解析のための方法及び核酸
GB0823445D0 (en) * 2008-12-23 2009-01-28 Univ Surrey Biomarker
US20120184447A1 (en) * 2009-06-26 2012-07-19 Reinhold Wasserkort Methods and Nucleic Acids for Analysis of Bladder Cell Proliferative Disorders
US9074251B2 (en) 2011-02-10 2015-07-07 Illumina, Inc. Linking sequence reads using paired code tags
WO2012106546A2 (en) 2011-02-02 2012-08-09 University Of Washington Through Its Center For Commercialization Massively parallel continguity mapping
JP2013074837A (ja) * 2011-09-30 2013-04-25 Sumitomo Chemical Co Ltd 哺乳動物由来の検体の癌化度を評価する方法
US9683230B2 (en) 2013-01-09 2017-06-20 Illumina Cambridge Limited Sample preparation on a solid support
EP2970951B1 (en) 2013-03-13 2019-02-20 Illumina, Inc. Methods for nucleic acid sequencing
AU2014364926B2 (en) 2013-12-20 2017-12-14 Illumina, Inc. Preserving genomic connectivity information in fragmented genomic DNA samples
KR102472027B1 (ko) * 2014-10-17 2022-11-30 일루미나 케임브리지 리미티드 근접 보존 전위
US10604759B2 (en) 2016-01-15 2020-03-31 City Of Hope Targeting glioblastoma stem cells through the TLX-TET3 axis
WO2017192221A1 (en) * 2016-05-05 2017-11-09 Exact Sciences Corporation Detection of lung neoplasia by analysis of methylated dna
CN106222080A (zh) * 2016-08-12 2016-12-14 深圳市天元印科技有限公司 肺癌预测系统
WO2020241816A1 (ja) * 2019-05-31 2020-12-03 国立大学法人大阪大学 新規な消化器がん治療剤およびそのスクリーニング方法
CN117144015A (zh) * 2023-10-05 2023-12-01 上海奕谱生物科技有限公司 DNA甲基化标志物TAGMe-7的鉴定及其在肿瘤检测中的用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5457183A (en) 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5245022A (en) 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
US5565552A (en) 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5574142A (en) 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
SE501439C2 (sv) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Sätt och anordning för analys av polynukleotidsekvenser
DE69417918T2 (de) 1993-11-30 2000-01-05 Mcgill University, Montreal Dna methyltransferase inhibierung
US5597696A (en) 1994-07-18 1997-01-28 Becton Dickinson And Company Covalent cyanine dye oligonucleotide conjugates
US5514758A (en) 1994-09-30 1996-05-07 The Goodyear Tire & Rubber Company Process for making latex for high performance masking tape
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
BR9712185A (pt) * 1996-10-01 1999-08-31 Rappold Hoerbrand Gudrun Gene do crescimento humano e região de gene de baixa estatura.
AU7829398A (en) 1997-06-09 1998-12-30 University Of Southern California A cancer diagnostic method based upon dna methylation differences
DE19754482A1 (de) 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
US5958773A (en) 1998-12-17 1999-09-28 Isis Pharmaceuticals Inc. Antisense modulation of AKT-1 expression
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
WO2005103296A2 (en) * 2004-03-30 2005-11-03 Vector Tobacco, Ltd. Global gene expression analysis of human bronchial epithelial cells exposed to cigarette smoke, smoke condensates, or components thereof
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
ES2801379T3 (es) * 2003-12-01 2021-01-11 Epigenomics Ag Métodos y ácidos nucleicos para el análisis de la expresión génica asociada con el desarrollo de trastornos proliferativos de células de próstata
WO2005111232A2 (en) * 2004-05-17 2005-11-24 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Silencing of tumor-suppressive genes by cpg-methylation in prostate cancer
WO2005123945A2 (en) * 2004-06-21 2005-12-29 Epigenomics Ag Epigenetic markers for the treatment of breast cancer
GB0414375D0 (en) * 2004-06-26 2004-07-28 Dingley Henrietta A Breathing device
EP2281902A1 (en) * 2004-07-18 2011-02-09 Epigenomics AG Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders
BRPI0518734A2 (pt) * 2004-11-30 2008-12-02 Veridex Llc prognàstico de cÂncer de pulmço
EP1904649A2 (en) * 2005-07-18 2008-04-02 Epigenomics AG Compositions and methods for cancer diagnostics comprising pan-cancer markers
ES2384071T3 (es) * 2007-01-19 2012-06-29 Epigenomics Ag Métodos y ácidos nucleicos para análisis de trastornos proliferativos celulares

Also Published As

Publication number Publication date
DK2258871T3 (da) 2014-08-11
CA2921557C (en) 2022-02-08
JP2010516234A (ja) 2010-05-20
IL199894A (en) 2014-11-30
ES2486190T3 (es) 2014-08-18
CA2675895A1 (en) 2008-07-24
HRP20140692T1 (hr) 2014-09-26
AU2008207110A1 (en) 2008-07-24
IL233548A (en) 2015-07-30
CA2675895C (en) 2016-03-22
EP2115165A2 (en) 2009-11-11
PT2258871E (pt) 2014-08-27
PL2258871T3 (pl) 2014-10-31
EA018010B1 (ru) 2013-04-30
ES2384071T3 (es) 2012-06-29
EA200970695A1 (ru) 2010-02-26
ATE549418T1 (de) 2012-03-15
WO2008087040A3 (en) 2008-10-16
WO2008087040A2 (en) 2008-07-24
JP5342456B2 (ja) 2013-11-13
CA2921557A1 (en) 2008-07-24
EP2115165B1 (en) 2012-03-14
SI2258871T1 (sl) 2014-09-30
EP2258871B1 (en) 2014-05-14
AU2008207110A2 (en) 2009-09-03
JP5818374B2 (ja) 2015-11-18
IL233548A0 (en) 2014-08-31
IL199894A0 (en) 2010-04-15
AU2008207110B2 (en) 2013-10-17
EP2258871A1 (en) 2010-12-08
JP2013150611A (ja) 2013-08-08

Similar Documents

Publication Publication Date Title
CY1115439T1 (el) Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου
BRPI0607508A2 (pt) métodos e ácidos nucléicos para análise de distúrbios proliferativos celulares
EP2484778A3 (en) Methods and nucleic acids for the detection of colorectal cell proliferative disorders
PH12014500063A1 (en) Methods and nucleic acids for determining the prognosis of a cancer subject
BR112013000745A2 (pt) "método para diagnosticar ou detectar câncer colorretal em um individuo, método de tratamento e método para monitorar a eficacia de tratamento de câncer colorretal em um indivíduo"
DE602008006318D1 (de) Element zur optischen Erfassung, Antriebsverfahren dafür und Sonde zur optischen Erfassung mit dem Element zur optischen Erfassung
ATE535805T1 (de) Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
BRPI0912927A2 (pt) "método de detectar um tumor independente de vegf em um indivíduo e método de tratar um tumor independente de vegf em um indivíduo"
EP2315849A4 (en) CIRCULATING MUTANT DNA FOR EVALUATING TUMOR DYNAMICS
ATE527385T1 (de) Mit tumoren assoziierte genetische variationen
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
EP2845910A4 (en) PROBE OR PROBE TO EVALUATE THE INFLUENCE OF ULTRAVIOLET RADIATION ON SKIN AND NUCLEIC ACID MICRO ARRAYS
WO2008011620A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2010007083A3 (en) Methods and nucleic acids for analyses of cell proliferative disorders
WO2009065511A3 (en) Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
EP2342360A4 (en) METHOD FOR MEASURING THE RESPONSE OF A PATIENT TO TELOMERASE THERAPY THERAPY
WO2009092597A3 (en) Methods and nucleic acids for analyses of prostate cancer
WO2007115213A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
ATE494390T1 (de) Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen
EP2443087A4 (en) DIFLUOROSULFINIUM (DISUBSTITUTED AMINO) SALTS, METHODS FOR THEIR PREPARATION AND USE AS DEOXOFLUORATION REAGENTS
WO2010070637A3 (en) Method for distinguishing between adrenal tumors
EP2371376A4 (en) METHOD AND REAGENTS FOR DIAGNOSIS, PREVENTION AND TREATMENT OF INSULIN RESISTANCE
FR2942807B1 (fr) Procede de detection, d'identification et/ou de quantification de nanotubes de carbone
EP2320917A4 (en) METHOD FOR PREVENTING, INHIBITING OR REVERSING TUMOR GENESIS AND IDENTIFYING COMPOUNDS THEREFOR
ATE490345T1 (de) Verwendung von oligonukleotidsonden und verfahren zur genomischen typisierung von erythrozytensystemen